Development of a Ready-to-Use Graphical Tool Based on Artificial Neural Network Classification: Application for the Prediction of Late Fecal Incontinence After Prostate Cancer Radiation Therapy.

Journal: International journal of radiation oncology, biology, physics
Published Date:

Abstract

PURPOSE: This study was designed to apply artificial neural network (ANN) classification methods for the prediction of late fecal incontinence (LFI) after high-dose prostate cancer radiation therapy and to develop a ready-to-use graphical tool.

Authors

  • Mauro Carrara
    Department of Medical Physics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: mauro.carrara@istitutotumori.mi.itmailto.
  • Eleonora Massari
    Department of Medical Physics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Alessandro Cicchetti
    Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Tommaso Giandini
    Department of Medical Physics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Barbara Avuzzi
    Department of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Federica Palorini
    Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Claudio Stucchi
    Department of Medical Physics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Giovanni Fellin
    Department of Radiation Oncology, Ospedale Santa Chiara, Trento, Italy.
  • Pietro Gabriele
    Department of Radiation Oncology, Istituto di Candiolo-Fondazione del Piemonte per l'Oncologia IRCCS, Candiolo, Italy.
  • Vittorio Vavassori
    Department of Radiation Oncology, Cliniche Gavazzeni-Humanitas, Bergamo, Italy.
  • Claudio Degli Esposti
    Department of Radiation Oncology, Ospedale Bellaria, Bologna, Italy.
  • Cesare Cozzarini
    Department of Radiation Oncology, San Raffaele Scientific Institute, Milano, Italy.
  • Emanuele Pignoli
    Department of Medical Physics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Claudio Fiorino
    Department of Medical Physics, San Raffaele Scientific Institute, Milano, Italy.
  • Tiziana Rancati
    Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Riccardo Valdagni
    Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Milan, Italy.